Search Results
58 items found for "Neel Freedman"
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
complexes and solute carriers, are relevant to immunology indications and rare diseases with high unmet need
- Adhesion GPCR Consortium Newsletter - May 2024
The excitement I felt when I first attended back in Boston is the same one I feel now that I am the organizer historically excluded demographics are finally included, this represents a building block to reinforce the need Mariachi song: I typically do not sing to these since they are dear to Mexican childhood memories, and I feel
- Subscribe to our monthly newsletter for FREE!
No need for that anymore! Dr. GPCR has it for you! 🔔 Subscribe to our monthly newsletter for FREE!
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
a disease where novel interventions that move beyond dopamine receptor antagonists are desperately needed While more work is needed to further elucidate the translational value of selectively targeting CB2 receptors
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
This emphasis may have caused other signaling pathways to be overlooked due to a need for adequate assay aberrant ERK activity can lead to uncontrolled cell proliferation and survival, highlighting the pressing need This further underscores the need for advanced assay technologies and a deep understanding of cellular
- Canonical chemokine receptors as scavenging “decoys”
continuously migrate by remaining responsive to chemokines, it dampens the inflammatory response when needed implications of its inhibition, an in-depth understanding of the underlying regulatory mechanisms is needed
- Newly launched antibody libraries put hard-to-drug targets within reach
November 2021 "Target class-specific libraries mean you need to screen less to identify high-quality protein-coupled receptors (GPCRs), more libraries, including better and more targeted libraries, are needed
- InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...
first-in-class small molecule agonists for a challenging orphan GPCR for a highly relevant therapeutic need
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
scientific perspective is broad, and we are happy to consider any research proposals from those in need
- N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 ...
GLP-2 system in the gut and the bones, potent and selective GLP-2 receptor (GLP-2R) antagonists are needed
- Emerging approaches for decoding neuropeptide transmission
These complex properties have driven the need for development of specialized tools that can sense neuropeptide
- CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse
To exert their functions requiring high sensibility and specificity, T cells need to integrate different
- Chronic itch: emerging treatments following new research concepts
However, many new targets, such as Mas-related GPCRs and unexpected new pathways need to be also explored
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation
- The Gluopsins: Opsins without the Retinal Binding Lysine
For chemoreception, the lysine is not needed.
- G-protein-coupled receptors as therapeutic targets for glioblastoma
of life during treatment coupled with brain tumour recurrence; thus, new treatments are desperately needed
- Immunomodulatory Role of Neuropeptides in the Cornea
neuropeptide activity for the treatment of corneal diseases with promising results, necessitating the need
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
layers of interconnected nodes which learn hierarchical representations of the data, eliminating the need field: 1) the quality and availability of data can be a challenge in AI-driven drug discovery; 2) the need Regulatory challenges, ethical considerations, and the need for interpretability of AI-driven models will need to be addressed to fully realize the potential of AI in GPCR drug discovery.
- All About Addgene: More Open and Reproducible Science with Materials Sharing
If you need a plasmid for your research or you want to share your materials, this is the place to go.
- Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric...
Thus, we need to know much more about the structures of receptor-ligand complexes at high resolution.
- TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms
However, a clear picture is needed to unravel TRPM3's full potential as experimental tool, diagnostic
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Hence, new β3 -AR agonists are needed as starting points for drug development.
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
Pancreatic ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed Jillian G and Immunology Pancreatic ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed
- Profiling Immune Cell and Platelet Transcriptomes
in immune cells underscores their potential roles in modulating immune responses and highlights the need
- In vitro assays for the functional characterization of (psychedelic) substances at the serotonin...
variety, leading to insufficiently described structure-activity relationships, hence illustrating the need
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
However, the increasing rate of cannabis use among pregnant women has presented an urgent need to investigate
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells...
therapeutic options are limited, novel targets and agents for therapeutic intervention are urgently needed
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
AlphaFold2 uses an AI-driven approach that eliminates the need for structural templates, allowing it